Lymphocytic colitis (LC) and collagenous colitis (CC) occur rarely in people with inflammatory bowel disease (IBD) but are linked with more active ... Read more
Gut microbes found in feces avoid triggering immune reactions that could lead to conditions like inflammatory bowel disease (IBD) by creating ... Read more
Zeposia (ozanimod), an investigational anti-inflammatory medicine, significantly increased clinical remission and mucosal healing in patients with ulcerative colitis (UC), a form ... Read more
Pterostilbene (PSB), a compound found in blueberries, can reduce the inflammatory activity of immune cells and limit colon inflammation in mice, ... Read more
ABX464, Abivax’s treatment candidate for ulcerative colitis (UC), continues to be safe and effective over time at keeping patients with moderate-to-severe UC ... Read more
Specialized cells of the intestine’s outer lining, called tuft cells, reduced chronic intestinal inflammation in a mouse model of Crohn’s disease when ... Read more
The first healthy volunteer has been dosed in an Australian Phase 1 clinical trial investigating IMU-856, a potential novel treatment for ... Read more
